Novartis transformed their digital strategy by incorporating ZONTAL's data platform to implement their FAIR data initiatives, achieving: • Faster technical development • Enhanced knowledge management • Increased operational efficiency Novartis's digital lab eliminated multiple systems and time-consuming data collection processes, enabling predictive simulations and streamlined knowledge exchange. Their data became easily accessible, transforming weeks of work into hours. 🌐 Learn how ZONTAL empowered Novartis's digital transformation: https://lnkd.in/gMp82ufT #DigitalLab #FAIRData #ZONTAL #Novartis #AI #MachineLearning
ZONTAL’s Post
More Relevant Posts
-
Streamlining Data for AI-Driven Drug Discovery! At BioDawn Innovations, we're excited to share insights on a critical aspect of modern drug discovery: converting raw inputs into canonical formats for analysis. As AI continues to revolutionize the field, the transformation of raw data into standardized, optimized formats is essential for effective analysis and modeling. Our latest blog explores: - The significance of transforming raw data for AI applications. - Common formats used to ensure data consistency and usability. - The profound impact this process has on accelerating drug discovery and enhancing research accuracy. By streamlining data into canonical formats, we unlock the true potential of AI, driving innovation and breakthroughs in developing new therapies. Stay informed with BioDawn Innovations as we explore the cutting edge of AI in drug discovery! #DrugDiscovery #AI #DataTransformation #BioDawnInnovations #HealthcareInnovation #BiomedicalResearch https://lnkd.in/dbbfMCi5
Streamlining Data: Converting Raw Inputs into Canonical Formats for Analysis in AI-Driven Drug Discovery | BioDawn Innovations
biodawninnovations.com
-
In this blog, Rohit Alimchandani, Head of Life Sciences, UK&I, Cognizant, discusses three large roadblocks hampering Life Sciences companies’ adoption of AI – issues around trust, skills, and risk and governance. He offers practical steps organizations can take to overcome them. This article draws upon Rohit’s keynote conversation at the Financial Times Global Pharma and Biotech Summit in November 2023. Watch the interview here: https://lnkd.in/eritSGEs #LifeSciences
How Life Sciences Companies Can Ride the AI Wave to Competitive Success
cognizant.com
-
Enabling unparalleled, world-class digital solutions Experienced Strategic Sales and Business Development professional
In this blog, Rohit Alimchandani, Head of Life Sciences, UK&I, Cognizant, discusses three large roadblocks hampering Life Sciences companies’ adoption of AI – issues around trust, skills, and risk and governance. He offers practical steps organizations can take to overcome them. This article draws upon Rohit’s keynote conversation at the Financial Times Global Pharma and Biotech Summit in November 2023. Watch the interview here: https://lnkd.in/gUyZgvfg #LifeSciences
How Life Sciences Companies Can Ride the AI Wave to Competitive Success
cognizant.com
-
In this blog, Rohit Alimchandani, Head of Life Sciences, UK&I, Cognizant, discusses three large roadblocks hampering Life Sciences companies’ adoption of AI – issues around trust, skills, and risk and governance. He offers practical steps organizations can take to overcome them. This article draws upon Rohit’s keynote conversation at the Financial Times Global Pharma and Biotech Summit in November 2023. Watch the interview here: https://lnkd.in/d9RJb3nN #LifeSciences
How Life Sciences Companies Can Ride the AI Wave to Competitive Success
cognizant.com
-
Using a workspace for advanced pharmacometrics modelling requires just a single line of code in the built-in R-Studio. Everything else is there - out of the box.
Jeff Barrett and Janani Murthy explore using nonlinear mixed effect modelling within the boundaries of our trusted research environment workspaces, with a specific focus on the nlmixr2 algorithm. https://lnkd.in/e3UqJR8V #DREnotDIY #trustedresearchenvironment #digitalresearchenvironment #tre #dre #dataanalytics #fairdata #dataanalytics #datascience #healthdata #clinicalresearch #clinicaldata #machinelearning #ai #fairdata #precisiondosing #pharmacotherapy #MIDD #MIPD #nlmixr #nlmixr2 #R #PKPD #PK #git #aiinhealthcare
Nonlinear Mixed Effect Modelling – The use of nlmixr2 in a DRE workspace
aridhia.com
-
In this blog, Rohit Alimchandani, Head of Life Sciences, UK&I, Cognizant, discusses three large roadblocks hampering Life Sciences companies’ adoption of AI – issues around trust, skills, and risk and governance. He offers practical steps organizations can take to overcome them. This article draws upon Rohit’s keynote conversation at the Financial Times Global Pharma and Biotech Summit in November 2023. Watch the interview here: https://lnkd.in/dkHz8znG #LifeSciences #BeCognizant
How Life Sciences Companies Can Ride the AI Wave to Competitive Success
cognizant.com
-
In this blog, Rohit Alimchandani, Head of Life Sciences, UK&I, Cognizant, discusses three large roadblocks hampering Life Sciences companies’ adoption of AI – issues around trust, skills, and risk and governance. He offers practical steps organizations can take to overcome them. This article draws upon Rohit’s keynote conversation at the Financial Times Global Pharma and Biotech Summit in November 2023. Watch the interview here: https://cogniz.at/4b5rNrd #LifeSciences
How Life Sciences companies can ride the AI wave to competitive success
cognizant.com
-
In this blog, Rohit Alimchandani, Head of Life Sciences, UK&I, Cognizant, discusses three large roadblocks hampering Life Sciences companies’ adoption of AI – issues around trust, skills, and risk and governance. He offers practical steps organizations can take to overcome them. This article draws upon Rohit’s keynote conversation at the Financial Times Global Pharma and Biotech Summit in November 2023. Watch the interview here: https://lnkd.in/eekDWfqy #LifeSciences
How Life Sciences Companies Can Ride the AI Wave to Competitive Success
cognizant.com
